The Latest Cardiac and Vascular News
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced the findings of a new consumer survey of more than 1,500 adults across the United States that sheds light on dangerous misconceptions and lack of awareness around heart disease, the leading killer in the U.S. The research shows that while most people are optimistic […]
SANTA CLARA, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) — Shockwave Medical, a pioneer in the development and commercialization of Intravascular Lithotripsy to treat complex calcified cardiovascular disease, today announced that Laura Francis has joined its Board of Directors and will serve as Chairperson of Shockwave’s Audit Committee. Ms. Francis currently […]
BURLINGTON, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2018 financial results on Tuesday, February 19, 2019, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and […]
TEL AVIV, Israel, Feb. 07, 2019 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, announced today that it will host a conference call and webcast on Tuesday, February 19, […]
SAN FRANCISCO, Feb. 07, 2019 (GLOBE NEWSWIRE) — InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, today announced that new U.S. patents have been issued by the U.S. Patent and Trademark Office (USPTO). The two new patents provide the company with significantly expanded […]
VANCOUVER, Feb. 7, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced the presentation of clinical data highlighting the low rate of hospitalization in patients treated with Brinavess® (vernakalant hydrochloride, IV), its antiarrhythmic drug for the rapid conversion of recent onset atrial […]
DUBLIN – February 7, 2019 – Medtronic plc (NYSE:MDT) announced today that it has received U.S. Food and Drug Administration (FDA) approval on an expanded indication for its Pipeline(TM) Flex embolization device.1 Previously indicated for the endovascular treatment of adults with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid […]
Toledo, Ohio, February 5, 2019 – VentureMed Group, Inc., a privately-held medical device company that develops and markets the FLEX Vessel Prep™ System to treat peripheral arterial disease (PAD) and stenoses of arteriovenous (AV) fistulas and grafts, announced today that J. Robert Paulson, Jr., has been appointed president and chief […]
FREMONT, Calif.–(BUSINESS WIRE)–Confluent Medical (formerly Nitinol Devices & Components “NDC”) launched today the High-Performance Nitinol Tubing Center of Excellence in response to increasing market demand for High-Performance Nitinol Tubing in challenging applications such as Transcatheter Heart Valves, Neurovascular, Electrophysiology, and Interventional Pulmonary. Confluent Medical is able to support the Nitinol […]
CHICAGO–(BUSINESS WIRE)–Omron Healthcare, Inc. and physIQ Inc. today announced a collaboration to integrate Omron’s innovative FDA-cleared device, HeartGuide®, the first wearable blood pressure monitor into the pinpointIQ®platform to monitor at-risk patients in an outpatient setting. The strategic collaboration aims to generate actionable clinical information for at-risk patients in an outpatient environment by leveraging […]
